Amphastar Pharmaceuticals AMPH FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's FX effect on cash?
- Amphastar Pharmaceuticals (AMPH) reported FX effect on cash of -$138K in Q1 2026.
- How has Amphastar Pharmaceuticals's FX effect on cash changed year-over-year?
- Amphastar Pharmaceuticals's FX effect on cash decreased by 216.9% year-over-year, from $118K to -$138K.
- What is the long-term trend for Amphastar Pharmaceuticals's FX effect on cash?
- Over 2 years (2022 to 2024), Amphastar Pharmaceuticals's FX effect on cash has grown at a -10.8% compound annual growth rate (CAGR), from -$239K to -$190K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.